Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Genetic Variation in the ABCB1 Gene May Lead to mRNA Level Chabge: Application to Gastric Cancer Cases

  • Mansoori, Maryam (Medical Cellular & Molecular Research Center Talghani Children Hospital of Golestan University of Medical Sciences) ;
  • Golalipour, Masoud (Medical Cellular & Molecular Research Center Talghani Children Hospital of Golestan University of Medical Sciences) ;
  • Alizadeh, Shahriar (Pathology Laboratory, Hakim Jorjani Hospital) ;
  • Jahangirerad, Ataollah (Oncology Department, 5th Golestan University Hospital) ;
  • Khandozi, Seyed Reza (Oncology Department, 5th Golestan University Hospital) ;
  • Fakharai, Habibollah (Novarx Corporation) ;
  • Shahbazi, Majid (Medical Cellular & Molecular Research Center Talghani Children Hospital of Golestan University of Medical Sciences)
  • Published : 2016.01.11
Download PDF
⟨ Previous Next ⟩

Abstract

Background: One of the major mechanisms for drug resistance is associated with altered anticancer drug transport, mediated by the human-adenosine triphosphate binding cassette (ABC) transporter superfamily proteins. The overexpression of adenosine triphosphate binding cassette, sub-family B, member 1 (ABCB1) by multidrug-resistant cancer cells is a serious impediment to chemotherapy. In our study we have studied the possibility that structural single-nucleotide polymorphisms (SNP) are the mechanism of ABCB1 overexpression. Materials and Methods: A total of 101 gastric cancer multidrug resistant cases and 100 controls were genotyped with sequence-specific primed PCR (SSP-PCR). Gene expression was evaluated for 70 multidrug resistant cases and 54 controls by real time PCR. The correlation between the two groups was based on secondary structures of RNA predicted by bioinformatics tool. Results: The results of genotyping showed that among 3 studied SNPs, rs28381943 and rs2032586 had significant differences between patient and control groups but there were no differences in the two groups for C3435T. The results of real time PCR showed over-expression of ABCB1 when we compared our data with each of the genotypes in average mode. Prediction of secondary structures in the existence of 2 related SNPs (rs28381943 and rs2032586) showed that the amount of ${\Delta}G$ for original mRNA is higher than the amount of ${\Delta}G$ for the two mentioned SNPs. Conclusions: We have observed that 2 of our studied SNPs (rs283821943 and rs2032586) may elevate the expression of ABCB1 gene, through increase in mRNA stability, while this was not the case for C3435T.

Keywords

References

  1. Andersen V, Ostergaard M, Christensen J, et al (2009). Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer, 9, 407. https://doi.org/10.1186/1471-2407-9-407
  2. Baker EK, El-Osta A (2003). The rise of DNA methylation and the importance of chromatin on multidrug resistance in cancer. Exp Cell Res, 290, 177-94. https://doi.org/10.1016/S0014-4827(03)00342-2
  3. de Oliveira J, Felipe AV, Neto RA, et al (2014). Association between ABCB1 immunohistochemical expression and overall survival in gastric cancer patients. Asian Pac J Cancer Prev, 15, 6935-8. https://doi.org/10.7314/APJCP.2014.15.16.6935
  4. Deborah White, Phuong Dang, Amity Venables, et al (2006). ABCB1 overexpression may predispose imatinib treated cml patients to the development of Abl kinase domain mutations, and may be an important contributor to acquired resistance. Blood, 108.
  5. Felipe AV, Moraes AA, de Oliveira J, et al (2014). Establishment and partial characterization of an epirubicin-resistant gastric cancer cell line with upregulated ABCB1. Asian Pac J Cancer Prev, 15, 6849-53. https://doi.org/10.7314/APJCP.2014.15.16.6849
  6. Fung KL, Gottesman MM (2009). A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta, 1794, 860-71. https://doi.org/10.1016/j.bbapap.2009.02.014
  7. Golalipour M, Mahjoubi F, Sanati MH, et al (2007). Gene dosage is not responsible for the upregulation of MRP1 gene expression in adult leukemia patients. Arch Med Res, 38, 297-304. https://doi.org/10.1016/j.arcmed.2006.10.016
  8. Gow JM, Hodges LM, Chinn LW, et al (2008). Substratedependent effects of human ABCB1 coding polymorphisms. J Pharmacol Exp Ther, 325, 435-42. https://doi.org/10.1124/jpet.107.135194
  9. Juliano RL, Ling V (1976). A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta, 455, 152-62. https://doi.org/10.1016/0005-2736(76)90160-7
  10. Mahjoubi F, Golalipour M, Ghavamzadeh A, et al (2008). Expression of MRP1 gene in acute leukemia. Sao Paulo Med J, 126, 172-9. https://doi.org/10.1590/S1516-31802008000300007
  11. Ren YQ, Han JQ, Cao JB, et al (2012). Association of MDR1 gene polymorphisms with susceptibility to hepatocellular carcinoma in the Chinese population. Asian Pac J Cancer Prev, 13, 5451-4. https://doi.org/10.7314/APJCP.2012.13.11.5451
  12. Roninson IB, Pastan I, Gottesman MM (1991). Isolation and characterization of the human MDR (P-glycoprotein) genes. In 'Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells', Eds Springer, 91-106
  13. Song P, Li S, Meibohm B, et al (2002). Detection of MDR1 single nucleotide polymorphisms C3435T and G2677T using realtime polymerase chain reaction: MDR1 single nucleotide polymorphism genotyping assay. AAPS PharmSci, 4, 29. https://doi.org/10.1208/ps040422
  14. Sonneveld P (2000). Multidrug resistance in haematological malignancies. J Intern Med, 247, 521-34. https://doi.org/10.1046/j.1365-2796.2000.t01-1-00689.x
  15. Ullah MF (2008). Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy. Asian Pac J Cancer Prev, 9, 1-6.
  16. Wallner J, Depisch D, Gsur A, et al (1993). MDR1 gene expression and its clinical relevance in primary gastric carcinomas. Cancer, 71, 667-71. https://doi.org/10.1002/1097-0142(19930201)71:3<667::AID-CNCR2820710303>3.0.CO;2-6
  17. Wang Z, Sew PH, Ambrose H, et al (2006). Nucleotide sequence analyses of the MRP1 gene in four populations suggest negative selection on its coding region. BMC Genomics, 7, 111. https://doi.org/10.1186/1471-2164-7-111
  18. Wang Z, Wang J, Chong S, et al (2009). Mining potential functionally significant polymorphisms at the ATP-bindingcassette transporter genes. Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), 7, 40-58. https://doi.org/10.2174/187569209787582330
  19. Wu DD, Zhang JX, Li J, et al (2014). Lack of association of the MDR1 C3435T polymorphism with susceptibility to gastric cancer and peptic ulcer: a systemic review and meta-analysis. Asian Pac J Cancer Prev, 15, 3021-7. https://doi.org/10.7314/APJCP.2014.15.7.3021
  20. Zhu CY, Lv YP, Yan DF, et al (2013). Knockdown of MDR1 increases the sensitivity to adriamycin in drug resistant gastric cancer cells. Asian Pac J Cancer Prev, 14, 6757-60. https://doi.org/10.7314/APJCP.2013.14.11.6757

Cited by

  1. Hypoxia Induces Multidrug Resistance via Enhancement of Epidermal Growth Factor-Like Domain 7 Expression in Non-Small Lung Cancer Cells vol.62, pp.3, 2017, https://doi.org/10.1159/000456066